Reveal Pharmaceuticals

Reveal is transforming medical insight, improving human health, and positively impacting the environment. Over 40M contrast-enhanced magnetic resonance imaging (MRI) scans are performed each year. Current MRI contrast agents all cause accumulation of the heavy metal gadolinium in the brain and body of every patient, and drive rising levels of gadolinium in surface waters. Reveal’s patented contrast agents are based on manganese, which is essential for life. Reveal’s gadolinium-free MRI contrast agent, RVP-001, currently in Phase 2 clinical studies, promises to directly replace current MRI contrast agents, benefiting patients and the planet.